mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy

被引：80

作者：

Deng, Zhuoya ^{[1
]}

Tian, Yuying ^{[1
]}

Song, Jianxun ^{[2
]}

An, Guangwen ^{[3
]}

Yang, Penghui ^{[1
]}

机构：

[1] Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Infect Dis, Beijing, Peoples R China

[2] Texas A&M Univ, Coll Med, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA

[3] 984 Hosp PLA, Dept Pharm, Beijing, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷

关键词：

mRNA vaccine; malignant tumor; delivery system; immunological mechanism; clinical trials; CYTOTOXIC T-LYMPHOCYTES; CLASS-II EPITOPES; GOLD NANOPARTICLES; IMMUNE-RESPONSES; DENDRITIC CELLS; IN-VITRO; POLYMERIC MICELLES; DRUG-DELIVERY; STRANDED RNA; RIG-I;

D O I：

10.3389/fimmu.2022.887125

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

mRNA therapy is a novel anticancer strategy based on in vitro transcription (IVT), which has potential for the treatment of malignant tumors. The outbreak of the COVID-19 pandemic in the early 21st century has promoted the application of mRNA technologies in SARS-CoV-2 vaccines, and there has been a great deal of interest in the research and development of mRNA cancer vaccines. There has been progress in a number of key technologies, including mRNA production strategies, delivery systems, antitumor immune strategies, etc. These technologies have accelerated the progress and clinical applications of mRNA therapy, overcoming problems encountered in the past, such as instability, inefficient delivery, and weak immunogenicity of mRNA vaccines. This review provides a detailed overview of the production, delivery systems, immunological mechanisms, and antitumor immune response strategies for mRNA cancer vaccines. We list some mRNA cancer vaccines that are candidates for cancer treatment and discuss clinical trials in the field of tumor immunotherapy. In addition, we discuss the immunological mechanism of action by which mRNA vaccines destroy tumors as well as challenges and prospects for the future.

引用

页数：15

共 99 条

[1] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[2] A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA [J].

Baiersdoerfer, Markus ;

Boros, Gabor ;

Muramatsu, Hiromi ;

Mahiny, Azita ;

Vlatkovic, Irena ;

Sahin, Ugur ;

Kariko, Katalin .

MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 15 :26-35

[3] A FIRST-IN-HUMAN STUDY OF INTRATUMORAL SAR441000, AN MRNA MIXTURE ENCODING IL-12SC, INTERFERON ALPHA2B, GM-CSF AND IL-15SUSHI AS MONOTHERAPY AND IN COMBINATION WITH CEMIPLIMAB IN ADVANCED SOLID TUMORS [J].

Bechter, Oliver ;

Utikal, Jochen ;

Baurain, Jean-Francois ;

Massard, Christophe ;

Sahin, Ugur ;

Derhovanessian, Evelyna ;

Ozoux, Marie-Laure ;

Marpadga, Rahul ;

Imedio, Esteban-Rodrigo ;

Acquavella, Nicolas ;

Loquai, Carmen .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 :A237-A238

[4] mRNA therapeutics in cancer immunotherapy [J].

Beck, Jan D. ;

Reidenbach, Daniel ;

Salomon, Nadja ;

Sahin, Ugur ;

Tureci, Ozlem ;

Vormehr, Mathias ;

Kranz, Lena M. .

MOLECULAR CANCER, 2021, 20 (01)

[5] Study of conformational transitions of i-motif DNA using time-resolved fluorescence and multivariate analysis methods [J].

Benabou, Sanae ;

Ruckebusch, Cyril ;

Sliwa, Michel ;

Avino, Anna ;

Eritja, Ramon ;

Gargallo, Raimundo ;

de Juan, Anna .

NUCLEIC ACIDS RESEARCH, 2019, 47 (13) :6590-6605

[6] Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].

Boczkowski, D ;

Nair, SK ;

Snyder, D ;

Gilboa, E .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472

[7] Triplex DNA Nanoswitch for pH-Sensitive Release of Multiple Cancer Drugs [J].

Chen, Xiaoxia ;

Chen, Tianshu ;

Ren, Lingjie ;

Chen, Guifang ;

Gao, Xiaohu ;

Li, Genxi ;

Zhu, Xiaoli .

ACS NANO, 2019, 13 (06) :7333-7344

[8]

CONRY RM, 1995, CANCER RES, V55, P1397

[9] Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses [J].

Cui, Can ;

Wang, Jiawei ;

Fagerberg, Eric ;

Chen, Ping-Min ;

Connolly, Kelli A. ;

Damo, Martina ;

Cheung, Julie F. ;

Mao, Tianyang ;

Askari, Adnan S. ;

Chen, Shuting ;

Fitzgerald, Brittany ;

Foster, Gena G. ;

Eisenbarth, Stephanie C. ;

Zhao, Hongyu ;

Craft, Joseph ;

Joshi, Nikhil S. .

CELL, 2021, 184 (25) :6101-+

[10] BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting [J].

Dagan, Noa ;

Barda, Noam ;

Kepten, Eldad ;

Miron, Oren ;

Perchik, Shay ;

Katz, Mark A. ;

Hernan, Miguel A. ;

Lipsitch, Marc ;

Reis, Ben ;

Balicer, Ran D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1412-1423

← 1 2 3 4 5 6 7 8 9 10 →